Accuray is a brand committed to expanding the curative power of radiation therapy, with the goal of helping clinicians get patients back to their lives faster. They provide a range of products and services that aim to improve the outcomes and quality of life for patients undergoing radiation therapy. Their product offerings include the Radixact System and C-RAD SGRT, which provide a comprehensive breast radiotherapy treatment solution.

With these systems, patients can benefit from tattoo-free set-up and DIBH treatments, ensuring precise and personalized care. Accuray also offers treatment delivery systems that deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) with true robotic precision. These systems can target tumors anywhere in the body, using integrated, AI-driven, real-time motion synchronization.

With over 25 years of evidence-based practice, Accuray radiation therapy technologies have been proven to be effective across a wide range of treatment sites and delivery techniques. They are continually innovating and improving their offerings to provide the best possible outcomes for patients. Accuray is dedicated to empowering clinicians and patients alike, providing integrated patient data management, centralized treatment planning, and adaptive workflows.

They also offer comprehensive services, including site planning and installation, training, technology upgrades, and ongoing support to ensure the success of their customers. With their unmatched service and commitment to maximizing uptime and ROI, Accuray is redefining the future of cancer care. They are revolutionizing the field with innovative technologies and solutions that enable clinicians to provide personalized, precise, and effective treatments for their patients